84 related articles for article (PubMed ID: 378337)
1. Live influenza vaccine: screening of attenuated virus strains by a 50% ciliary activity inhibition test in organ cultures of ferret trachea.
Boudreault A
Can J Microbiol; 1979 Mar; 25(3):279-84. PubMed ID: 378337
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ciliary activity in organ cultures of ferret trachea in reference to genetic and biological characters in influenza virus strains.
Diaz-Rodriguez P; Boudreault A
Can J Microbiol; 1982 Jul; 28(7):809-14. PubMed ID: 6756625
[TBL] [Abstract][Full Text] [Related]
3. In vitro markers for measuring residual virulence for men of live attenuated influenza viruses.
Boudreault A; Diaz-Rodriguez P; Lecomte J
Dev Biol Stand; 1977 Jun 1-3; 39():33-40. PubMed ID: 604117
[TBL] [Abstract][Full Text] [Related]
4. An 'in vitro' marker of attenuation for live influenza virus vaccine candidates.
Mostow SR; Flatauer S; Martinko J
Dev Biol Stand; 1975; 28():354-62. PubMed ID: 1126579
[TBL] [Abstract][Full Text] [Related]
5. Criteria in the evaluation of live intranasal influenza virus vaccines.
Zygraich N
Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
[TBL] [Abstract][Full Text] [Related]
6. Temperature-sensitive mutants of influenza virus. XIII. Evaluation of influenza A/Hong Kong/68 and A/Udorn/72 ts and wild-type viruses in tracheal organ culture at permissive and restrictive temperatures.
Mostow SR; Flatauer S; Paler M; Murphy BR
J Infect Dis; 1977 Jul; 136(1):1-6. PubMed ID: 886200
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
[TBL] [Abstract][Full Text] [Related]
8. Behavior of vaccine revertants of temperature-sensitive mutants of influenza virus in ferret tracheal organ culture.
Mostow SR; Hopkins JA; Wright PF
Infect Immun; 1979 Oct; 26(1):193-6. PubMed ID: 500202
[TBL] [Abstract][Full Text] [Related]
9. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
Suguitan AL; McAuliffe J; Mills KL; Jin H; Duke G; Lu B; Luke CJ; Murphy B; Swayne DE; Kemble G; Subbarao K
PLoS Med; 2006 Sep; 3(9):e360. PubMed ID: 16968127
[TBL] [Abstract][Full Text] [Related]
10. Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).
Potter CW; Jennings R; Ali MJ; Wood JM; Dunleavy U; Tyrrell DA
Epidemiol Infect; 1987 Oct; 99(2):501-15. PubMed ID: 3315713
[TBL] [Abstract][Full Text] [Related]
11. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
Delem A
Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
[TBL] [Abstract][Full Text] [Related]
12. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
[TBL] [Abstract][Full Text] [Related]
13. Study of the immunogenicity of trivalent inactivated whole-virion influenza vaccine in human volunteers.
Moffat MA; Pennington TH; Robertson AM; van Voorthuizen WF
J Biol Stand; 1982 Apr; 10(2):83-90. PubMed ID: 7096364
[No Abstract] [Full Text] [Related]
14. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
Freestone DS
Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
[TBL] [Abstract][Full Text] [Related]
16. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
17. Immunity to influenza virus infection induced by heterologous, inactivated vaccines.
Potter CW; Jennings R; Nicholson K
Med Microbiol Immunol; 1978 Nov; 166(1-4):99-108. PubMed ID: 723794
[No Abstract] [Full Text] [Related]
18. Immunity to influenza in ferrets. XIV: Comparative immunity following infection or immunization with live or inactivated vaccine.
Fenton RJ; Clark A; Potter CW
Br J Exp Pathol; 1981 Jun; 62(3):297-307. PubMed ID: 7018552
[TBL] [Abstract][Full Text] [Related]
19. Specific immunity to influenza virus in ferret organ cultures.
Cogliano RC; Small PA
Br J Exp Pathol; 1978 Feb; 59(1):21-31. PubMed ID: 638028
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine.
Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ
J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
